Personal profile
Free keywords
- Immunology
- cancer immunotherapy
- Oncoimmunology
- Prostate cancer
- Head and neck cancer
- Cancer and Oncology
- Biopharmaceuticals
- cytokines
- Checkpoint inhibitors
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
-
SDG 3 Good Health and Well-being
Fingerprint
- 1 Similar Profiles
Collaborations the last five years
-
An explorable model of an adverse outcome pathway of cytokine release syndrome related to the administration of immunomodulatory biotherapeutics and cellular therapies
Mazein, A., Lopata, O., Reiche, K., Sewald, K., Alb, M., Sakellariou, C., Gogesch, P., Morgan, H., Neuhaus, V., Pham, N. N., Sommer, C., Perkins, E., Fogal, B., Shoaib, M., Schneider, R., Satagopam, V. & Ostaszewski, M., 2025, In: Frontiers in Immunology. 16, 1601670.Research output: Contribution to journal › Article › peer-review
Open Access -
Fine tuning of the innate and adaptive immune responses by Interleukin-2
Sakellariou, C., Roser, L. A., Schiffmann, S. & Lindstedt, M., 2024, In: Journal of Immunotoxicology. 21, 1, 2332175.Research output: Contribution to journal › Article › peer-review
Open Access -
IL-2-mediated hepatotoxicity: knowledge gap identification based on the irAOP concept
Roser, L. A., Sakellariou, C., Lindstedt, M., Neuhaus, V., Dehmel, S., Sommer, C., Raasch, M., Flandre, T., Roesener, S., Hewitt, P., Parnham, M. J., Sewald, K. & Schiffmann, S., 2024, In: Journal of Immunotoxicology. 21, 1, 2332177.Research output: Contribution to journal › Article › peer-review
Open Access -
Revival of recombinant IL-2 therapy–approaches from the past until today
Roser, L. A., Sommer, C., Ortega Iannazzo, S., Sakellariou, C., Waibler, Z. & Gogesch, P., 2024, In: Journal of Immunotoxicology. 21, sup1, p. S38-S47Research output: Contribution to journal › Review article › peer-review
Open Access -
Using interactive platforms to encode, manage and explore immune-related adverse outcome pathways
Mazein, A., Shoaib, M., Alb, M., Sakellariou, C., Sommer, C., Sewald, K., Reiche, K., Gogesch, P., Roser, L. A., Ortega Iannazzo, S., Sheth, S., Schiffmann, S., Waibler, Z., Neuhaus, V., Dehmel, S., Satagopam, V., Schneider, R., Ostaszewski, M. & Gu, W., 2024, In: Journal of Immunotoxicology. 21, sup1, p. S5-S12Research output: Contribution to journal › Article › peer-review
Open Access
-
Impact of CD40 therapies on the tumor microenvironment
Andersson, H. (Research student), Lindstedt, M. (PI), Ellmark, P. (Assistant supervisor), Sakellariou, C. (Assistant supervisor) & Hägerbrand, K. (Assistant supervisor)
2023/04/01 → 2027/03/31
Project: Research
-
Immune Safety Avatar - Nonclinical mimicking of the immune system effects of immunomodulatory therapies
Sakellariou, C. (Researcher) & Lindstedt, M. (PI)
2019/12/01 → 2025/11/30
Project: Research